Maneesh Pharmaceuticals Limited Pyrazinamide Export Data — India (DGFT 2022–2026)

Name: Maneesh Pharmaceuticals Limited Pyrazinamide Export Records India — #4 Exporter, 69 Shipments, $3.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Pyrazinamide

India Pharmaceutical Trade Intelligence

$962.4M90 Suppliers131 CountriesHS 30049057

ExportsIndia → CONGO DR55.5%India → NIGERIA26.0%

ImportsUNITED STATES → India$5.0K GERMANY → India$2.6K

#1 Supplier: LUPIN LIMITED #1 Buyer: NATIONAL TUBERCULOSIS

Maneesh Pharmaceuticals Limited — Pyrazinamide Exporter #4 | $3.9M Trade Value | TransData Nexus | TransData Nexus

Maneesh Pharmaceuticals Limited — Pyrazinamide Exporter Profile

Indian Pharmaceutical Exporter · #4 for Pyrazinamide · $3.9M export value · DGFT Verified

Maneesh Pharmaceuticals Limited is the #4 Indian exporter of Pyrazinamide with $3.9M in export value and 69 verified shipments. Maneesh Pharmaceuticals Limited holds a 0.4% market share in Pyrazinamide exports across 24 countries. The company exports 6 pharmaceutical products worth $31.9M across 4 therapeutic categories.

Maneesh Pharmaceuticals Limited — Pyrazinamide Export Profile: Buyers & Destinations

Maneesh Pharmaceuticals Limited Pyrazinamide export treemap — buyers and destination countries | TransData Nexus

Where Does Maneesh Pharmaceuticals Limited Export Pyrazinamide?

Country	Value	Shipments	Share
PHILIPPINES	$237.5K	9	10.4%
KENYA	$203.9K	7	8.9%
SUDAN	$200.0K	4	8.7%
AFGHANISTAN	$200.0K	4	8.7%
INDONESIA

Who Are the Top Buyers of Pyrazinamide from Maneesh Pharmaceuticals Limited?

Buyer	Country	Value	Orders
AMBICA INTERNATIONAL CORPORATION	PHILIPPINES	$237.5K	9
SEKRETARIAT DITJEN PENCEGAHAN DAN P	INDONESIA	$200.0K	4
UNOCO COMPOUND JALALABAD ROAD KABUL	AFGHANISTAN	$150.0K	3
GITTOES PHARMACEUTICALS	UGANDA	$118.3K	4
REPUBLIQUE DU CONGO PROGRAMME DES NATIONS UNIESPOUR LE	CONGO	$100.0K	2
FEDERAL MINISTRY OF HEALTH DIRECTORATE OF INTERNATIONAL HEALTHGRANTS	SUDAN	$100.0K	2
COSPHARM INV T/A M PLUS PHARMACEUTI	NAMBIA	$100.0K	2
5 KAMPALA	KENYA	$86.7K	2
UNITED NATIONS DEVELOPMENT PROGRAMM	IRAN	$83.2K	2
MSF AZG	NETHERLANDS	$63.6K	6

Maneesh Pharmaceuticals Limited supplies Pyrazinamide to 40 buyers globally. The largest buyer is AMBICA INTERNATIONAL CORPORATION (PHILIPPINES), followed by SEKRETARIAT DITJEN PENCEGAHAN DAN P (INDONESIA) and UNOCO COMPOUND JALALABAD ROAD KABUL (AFGHANISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Pyrazinamide Formulations Does Maneesh Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL 275MG TABS EACH CARTON OF 24X28 TABS 2690 CARTONS	$150.0K	3
6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ISONIAZID 75 MG/PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(25602 CNOS	$150.0K	3
RIFAMPICIN+ISONIAZID+PYRAZINAMIDE+ETHAMB	$100.0K	4
RIFAMPICIN 150MG/ISONIAZID 75MG/PYRAZINAMIDE 400MG /ETHAMBUTOL 275MG TABS B.NOSL3545SL3546SL3547 MANUFACTURING D.08-23EXP.7-26	$100.0K	2
RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL 275MG TABS EACH CARTON OF 24X28 TABS	$100.0K	2
RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL HCL 275MG TABS EACH CARTON OF 24x28 TABS	$100.0K	2
RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL HCL 275MG TABS EACH CARTON OF 24X28 TABS	$97.8K	4
RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL HCL 275MG TABS EACH CARTON OF 24X28 TABSNOS	$85.0K	4
RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL 275MG TABSEACH CARTON OF 24x28 TABS 374 CARTONS	$62.0K	3
RIFAMPICIN 150MG ISONIAZID 75MG PYRAZINAMIDE 400MG ETHAMBUTOL 275MG TABS EACH CARTON OF 24x28 TABS 1859 CTN	$50.0K	1

Maneesh Pharmaceuticals Limited exports 52 distinct Pyrazinamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHA with 3 shipments worth $150.0K.

How Does Maneesh Pharmaceuticals Limited Compare to Nearest Pyrazinamide Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	LUPIN LIMITED	$16.1M	321	49	$50.0K
3	MACLEODS PHARMACEUTICALS LIMITED	$7.2M	143	51	$50.0K
4	MANEESH PHARMACEUTICALS LIMITED ★	$3.5M	69	24	$50.0K
5	SVIZERA LABS PRIVATE LIMITED	$1.9M	39	12	$50.0K
6	MICRO LABS LIMITED	$1.8M	64	23	$27.7K

Maneesh Pharmaceuticals Limited ranks #4 among 90 Indian Pyrazinamide exporters. Average shipment value of $50.0K compared to the market average of $557.3K. The closest competitors by value are LUPIN LIMITED and MACLEODS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Pyrazinamide Exports?

Port	Shipments	% Share
SAHAR AIR	357	24.5%
SAHAR AIR CARGO ACC (INBOM4)	170	11.7%
DELHI AIR	154	10.6%
DELHI AIR CARGO ACC (INDEL4)	126	8.6%
Bombay Air	94	6.4%
NHAVA SHEVA SEA (INNSA1)	87	6.0%
JNPT	87	6.0%
JNPT/ NHAVA SHEVA SEA	81	5.6%

Geopolitical & Trade Policy Impact on Maneesh Pharmaceuticals Limited's Pyrazinamide Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Maneesh Pharmaceuticals. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceutical imports, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk. While Indian generics have largely remained exempt, any expansion of tariffs could adversely affect companies like Maneesh Pharmaceuticals, which rely on the US market for a significant portion of their exports. (pharma.economictimes.indiatimes.com)

The recent India-European Union Free Trade Agreement (FTA), signed on January 27, 2026, offers a favorable development. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing Maneesh Pharmaceuticals with enhanced access to European markets. This agreement is expected to boost India's pharmaceutical exports to the EU, presenting growth opportunities for the company. (en.wikipedia.org)

Maneesh Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements. Indian companies have faced increased scrutiny, leading to higher compliance costs and, in some cases, reduced export volumes. (transdatanexus.com)

For Maneesh Pharmaceuticals, maintaining adherence to these evolving standards is crucial to sustain and expand its export markets. Continuous investment in quality assurance and regulatory compliance will be essential to navigate the complex global regulatory environment and to meet the expectations of international partners and consumers.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Pyrazinamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Maneesh Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 77 individual customs records matching Maneesh Pharmaceuticals Limited exporting Pyrazinamide, covering 52 formulations to 25 countries via 40 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 131+ countries, 434+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Pyrazinamide

Pyrazinamide

Maneesh Pharmaceuticals Limited — Pyrazinamide Exporter Profile

Maneesh Pharmaceuticals Limited — Pyrazinamide Export Profile: Buyers & Destinations

Where Does Maneesh Pharmaceuticals Limited Export Pyrazinamide?

Who Are the Top Buyers of Pyrazinamide from Maneesh Pharmaceuticals Limited?

What Is India's Total Pyrazinamide Export Value and How Much Does Maneesh Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Maneesh Pharmaceuticals Limited's Pyrazinamide Exports?

How Does Maneesh Pharmaceuticals Limited Compare to Other Indian Pyrazinamide Exporters?

What Pyrazinamide Formulations Does Maneesh Pharmaceuticals Limited Export?

How Does Maneesh Pharmaceuticals Limited Compare to Nearest Pyrazinamide Exporters?

Which Indian Ports Ship Pyrazinamide Exports?

What Other Tuberculosis Medications Products Does Maneesh Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Maneesh Pharmaceuticals Limited's Pyrazinamide Exports

Maneesh Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Maneesh Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Pyrazinamide Export Data from Maneesh Pharmaceuticals Limited

Pyrazinamide Stats

Company Overview

Top Products by Maneesh Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source